SCHEMBL22728423

SCHEMBL22728423

N#CC1(Cc2c(F)cc(C(F)(F)P)cc2F)CCN(C(=O)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 8/20 0.53
▸ CYP3A4 P08684 4/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.34
▸ PKM P14618 1/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ ABL1 P00519 3/20 0.32
▸ BCR P11274 3/20 0.32
▸ USP2 O75604 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ USP30 Q70CQ3 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453644 0.94 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL22719329 0.94 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL22719482 0.90 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL29453697 0.90 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL22719231 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL29453743 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL29453730 0.87 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL22719220 0.87 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL22719456 0.85 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19
SCHEMBL29453672 0.85 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C9CYP2C8CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback